Products: neuro-robot. Risk band: Elevated
RobotRisk index 24.4/100 (severity- and time-weighted incidents) · ranked 11 of 25 among Medical robotics companies with incidents (173 tracked).
Analyst brief
Monteris Medical's record contains four entries spanning October 2014 to January 2019, all recalls, including two FDA Class I actions in 2016 and 2017 for the NeuroBlate System and its SideFire Select laser probe component, each rated severity 4. This is an entirely regulatory-driven record with no press-only incidents, and the recurrence of recalls against the same NeuroBlate laser-ablation platform across a five-year span indicates a repeated rather than isolated failure pattern concentrated in one product line. The presence of two Class I recalls — the FDA's highest-severity recall classification — is the dominant severity signature in this record. Monteris Medical's index of 24.4 ranks 11 of 25 companies in Medical robotics with incident history.
Risk index
24.4/100RobotRisk index
22.1/100Median index across the 25 Medical robotics companies with incident history (173 tracked, 148 with none)
11 of 25Rank in Medical robotics (of 25 with incident history)